This compound is primarily utilized in pharmaceutical research and development, particularly in the synthesis of novel drug candidates. It serves as a key intermediate in the production of active pharmaceutical ingredients (APIs) targeting neurological and psychiatric disorders, such as anxiety, depression, and cognitive impairments. Its structural features, including the spirocyclic and diaza components, make it valuable for designing molecules with enhanced binding affinity and selectivity for specific biological targets, such as receptors or enzymes in the central nervous system. Additionally, it is employed in medicinal chemistry to optimize pharmacokinetic properties, such as solubility and metabolic stability, during the drug discovery process.